Needham analyst Bernie McTernan maintains Super Group (SGHC) (NYSE:SGHC) with a Buy and lowers the price target from $8 to $7.
FDA Authorizes Lucira’s Over-the-Counter At-Home Test To Detect Both Influenza, COVID-19 Viruses
https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-over-counter-home-test-detect-both-influenza-and-covid-19-viruses